Last Updated: June 22, 2026

VILAZODONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Vilazodone

A generic version of VILAZODONE was approved as vilazodone hydrochloride by TEVA PHARMS USA on September 30th, 2019.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VILAZODONE?
  • What are the global sales for VILAZODONE?
  • What is Average Wholesale Price for VILAZODONE?
Summary for VILAZODONE
US Patents:0
Applicants:5
NDAs:5
Drug Prices: Drug price information for VILAZODONE
What excipients (inactive ingredients) are in VILAZODONE?VILAZODONE excipients list
DailyMed Link:VILAZODONE at DailyMed

US Patents and Regulatory Information for VILAZODONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208209-001 Apr 27, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Apotex VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208228-001 Jul 7, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alembic VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208202-001 Jan 10, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Invagen Pharms VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208200-002 Apr 7, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Apotex VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208228-002 Jul 7, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for VILAZODONE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.